April 6-9, 2019
Rome, Italy
Submit your ideas for a potential Keynote Address, Plenary Session, or Hot Topic Session at the 2019 ICPE, to be held August 24-28, 2019 in Philadelphia, Pennsylvania. ICPE is developed organically from the interests of those within the society with all ISPE members welcome to contribute. If you have a topic for consideration, please complete our online form by September 27.
ISPE is now accepting abstracts from students for oral/poster presentations in the area of pharmacoepidemiology and drug safety for our 2019 Mid-Year Meeting in Rome, Italy, held at the Radisson Blu Hotel, from April 6-9, 2019. Current full-time students that are the lead author on the research study are invited to submit abstracts by November 16, 2018, for presentation at this meeting. There will be 12 student oral presentations and 24 student poster presentations.
Recordings of the pre-ICPE courses and plenary sessions are expected to be available in the Member Network by late September. Slides of presentations are available in the My ISPE Conference module.
The Society seeks proposals for manuscripts that could be used for guideline development or reference documents for pharmacoepidemiology, including pharmacovigilance, drug utilization research, outcomes research, comparative effectiveness research, and therapeutic risk management. Deadline to submit to info@pharmacoepi.org and September 27, 2018. Manuscript proposals from ISPE members addressing any topic will be considered. For more information, including response format and review criteria, click here.
The task force set up by European Union (EU) regulators to better address potential problems with medicines’ supply and to avoid shortages recently published its work programme for the coming two years. The task force will organize a multi-stakeholder workshop on November 8-9, 2018 to gather stakeholders’ perspectives on how to address availability issues and to include their input into the deliverables of the task force. It will bring together all stakeholders impacted, including patients, consumers, healthcare professionals, industry, wholesalers/distributors, parallel distributors, academia and regulators. The meeting will take place at the EMA offices (30 Churchill Place, Canary Wharf, E14 5EU London, United Kingdom). The first day (November 8) will be a technical meeting where industry stakeholders will be invited to join regulators with a view to gathering technical feedback on the work of the Task Force. The second day (November 9) will be a multi-stakeholder meeting where industry stakeholders, healthcare professionals, patients/consumers and academia/NGOs will be invited to join regulators with a view to gathering multi-stakeholders’ perspectives on the work of the Task Force and discuss how these can contribute to its deliverables. For more information contact MSQDmeeting@ema.europa.eu
